Tag Archives: ADXS

Thursday’s Highlights at Noon: Synergy Pharmaceuticals Inc (SGYP), Biocept Inc (BIOC), Civeo Corp (CVEO), Advaxis (ADXS), Curis Inc (CRIS)

So far Thursday, January 24, NASDAQ is up 0.82% and the S&P is up 0.23%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; Synergy Pharmaceuticals Inc (SGYP – Research Report), Biocept Inc (BIOC

Wednesday’s Highlights at Noon: Biocept Inc (BIOC), Orexigen (OREX), ImmunoCellular Therapeutics (IMUC), Advaxis (ADXS), Curis Inc (CRIS)

So far Wednesday, January 16, NASDAQ is down -0.16% and the S&P is up 0.28%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; Biocept Inc (BIOC – Research Report), Orexigen (OREX – Research

Friday’s Midday Movers: ImmunoCellular Therapeutics (IMUC), Rosetta Genomics Ltd (ROSG), Advaxis (ADXS), Idera (IDRA), Anthera Pharmaceuticals (ANTH)

So far Friday, December 14, NASDAQ is down -1% and the S&P is down -1.41%. Here are this morning’s most active stocks: ImmunoCellular Therapeutics (IMUC – Research Report), Rosetta Genomics Ltd (ROSG – Research Report), Advaxis (ADXS – Research Report),

A Director at Advaxis (NASDAQ: ADXS) is Buying Shares

Today, a Director at Advaxis (NASDAQ: ADXS), Roni Appel, bought shares of ADXS for $40K. This recent transaction increases Roni Appel’s holding in the company by 26.92% to a total of $128.4K. See today’s analyst top recommended stocks >> Currently,

Analysts Are Bullish on These Healthcare Stocks: ADXS, CCXI

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Advaxis (NASDAQ: ADXS) and ChemoCentryx (NASDAQ: CCXI) with bullish sentiments. Advaxis (NASDAQ: ADXS) In a report released today, Swayampakula Ramakanth from H.C.

Analysts Offer Insights on Healthcare Companies: Advaxis (NASDAQ: ADXS) and Nektar Therapeutics (NASDAQ: NKTR)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Advaxis (NASDAQ: ADXS) and Nektar Therapeutics (NASDAQ: NKTR) with bullish sentiments. Advaxis (NASDAQ: ADXS) In a report released today, Swayampakula Ramakanth from